摘要
以肝细胞场(HCC)患者手术切除标本为研究材料,采用高效液相色谱荧光法检测组织中的黄曲霉毒素B1(AFB1),嵌套式多聚酶链反应技术检测组织中的HBVDNA和HCVRNA。在69.2%(18/26例)的HCC患者中检出了3.65-89.06ng不等的AFB1/g肝组织;HBVDNA和HCVRNA检出率分别为90.5%(57/63例)和12.7%(8/63例)。其中,AFB1和HBVDNA重叠检出率为61.5%(16/26例),HBVDNA和HCVRNA重叠检出率为7.9%(5/63例),4例HCC患者重叠检出了AFB1、HBVDNA和HCVRNA;同步检测对照组5例,无1例出现这种情况。结果表明,上述3种因素均与人类肝癌密切相关,并且可能存在协同致癌效应。
nalysis was made by using human liver tissues from hepatectomy specimens of patients with hepatocellular carcinoma (HCC) to detect aflatoxin B1 (AFB1) by high performance liq- uid chromatography (HPLC) , and HBV DNA by nested PCR technique ,and HCV RNA by reverse transcription nested PCR technique. AFB1 was detected in 18 of 26 (69. 2% ) patients with HCC,ranging from 3. 65-89. 06ng/g liver tissue. The positive rates of HBV DNA and HCV RNA were 90. 5%(57/63) and 12. 7%(8/63) respectively. Among these patients, AFB1 and HBV DNA were simultaneously detected in 61. 5 % ( 16/26 ) , and HCV RNA and HBV DNA in 7. 9% (5/63). Furthermore, AFB1,HBV DNA and HCV RNA were detected simultaneously in four patients with HCC. Whereas all of subjects of control group were negative for these three factors. These results suggested that AFB1 , HBV and HCV were as- sociated closely with human HCC , and these three factors might play a synergistic role in the oncogenesis of HCC.
出处
《中山医科大学学报》
CSCD
1996年第1期20-23,共4页
Academic Journal of Sun Yat-sen University of Medical Sciences
关键词
肝肿瘤
肝炎病毒
黄曲霉毒素
分析
liver neoplasms/genetics
aflatoxin/analysis
hepatitis B virus/genet- ics
hepatitis C virus/genetics
gene ,viral